RANDI WATKINS: Open Payments
NPI 1669635926 · CARTHAGE, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$633 in 34 payments from 13 companies in 2025. Trend: 2023 $660 · 2024 $578 · 2025 $633
Food & beverage: $633
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 12 | $244 |
| ABBVIE INC. | 3 | $56 |
| Novo Nordisk Inc | 3 | $53 |
| Averitas Pharma Inc. | 2 | $50 |
| GlaxoSmithKline, LLC. | 2 | $35 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $35 |
| PFIZER INC. | 2 | $31 |
| Phathom Pharmaceuticals, Inc. | 3 | $27 |
| Verona Pharma, Inc. | 1 | $27 |
| Abbott Laboratories | 1 | $22 |
Products named: BREZTRI, FARXIGA, AIRSUPRA, Ozempic, QUTENZA, LINZESS, Kerendia, VOQUEZNA.
Industry payments across MS — which companies pay providers there.
